Brief: Senzime Q1 Operating Expenses SEK 35.562 Million
22/04/2026 07:00
Apr 22 (Reuters) - Senzime Q1 sales SEK 23.233 million. Q1 EPS SEK -0.14 Q1 adjusted gross margin 63.1%
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona